1 year return (CAGR)
-55.93%
Elevai Labs, Inc. Common Stock Exchange (NASDAQ, USD)
ELAB
2.64
+0.07 (+2.72%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
2.14M
Price/Sales
0.83
Ent value
3.82M
Price/Book
0.13
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.57 |
| Daily high | 2.65 |
| Daily low | 2.52 |
| Daily Volume | 7K |
| All-time high | 19796.00 |
| 1y analyst estimate | - |
| Beta | -0.30 |
| EPS (TTM) | -27.65 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ELAB | S&P500 | |
| Current price drop from All-time high | -99.99% | -1.25% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 19 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -93.66% | -10.65% |
| Avg time to new high | 147 days | 12 days |
| Max time to new high | 733 days | 1805 days |
News
